Overview

Smoking Cessation Using Motivational Therapy and Varenicline

Status:
Completed
Trial end date:
2013-06-20
Target enrollment:
Participant gender:
Summary
People that are infected with HIV appear to be especially susceptible to the adverse effects of cigarette smoking. The purpose of this study is to determine if quitting smoking by using a specialized smoking cessation treatment can prevent one from developing accelerated lung damage, particularly emphysema.
Phase:
N/A
Details
Lead Sponsor:
Philip Diaz
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Nicotine
Varenicline